Plunging sales of Merck’s blockbuster HPV vaccine in China have caused a sharp fall in the US pharma group’s earnings.
In results published on Tuesday, Merck reported that after the effect of currency fluctuations were stripped out, net income fell to $4.4bn in the second quarter, a 17 per cent decline on the same period a year ago.
Merck has previously warned about the Gardasil vaccines sales slump, saying in February that it was halting shipments to China to help a key local supplier reduce excess inventory.
您已閱讀40%（513字），剩余60%（785字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。